Has Douglas Lowery, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,531 in general payments to Douglas Lowery, MD across 108 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Douglas Lowery, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Douglas Lowery, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Douglas Lowery, MD

Otolaryngology · Birmingham, ALNPI 1609819168

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.7% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,008, more than ten times the $26 reported in 2019.

$2,531in general payments, 2019–2025

Across 108 payments — averaging $23.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Optinose US, Inc.$519
GSK$514
Regeneron Healthcare Solutions, Inc.$467
Sanofi$431
Inspire Medical Systems, Inc.$223
Sanofi-aventis U.S. LLC$99
plus $279 from 7 others

What the payments were for

Food & beverage$2,39895%
Education$1335%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Optinose US, Inc.	35	$519
GSK	26	$514
Regeneron Healthcare Solutions, Inc.	19	$467
Sanofi	12	$431
Inspire Medical Systems, Inc.	3	$223
Sanofi-aventis U.S. LLC	1	$99
Smith+Nephew	3	$76
Amgen	2	$59
Intersect ENT, Inc.	2	$50
Med-el Corporation	1	$31
Advanced Bionics, LLC	2	$27
Alk-abello, Inc	1	$18
Paratek Pharmaceuticals, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$180

How this compares

$2,531 in reported general payments places this provider in the 65th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama →

Medicare billing

Part B allowed, 2024

$143,192

Medicare patients

334

Services billed

3,528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	163	$5,179
Dexlansoprazole DrDexlansoprazole	12	$2,501
Doxycycline Monohydrate	118	$2,244
Omeprazole	184	$2,081
Mometasone Furoate	85	$1,929
Azelastine Hcl	37	$1,170
Montelukast Sodium	83	$1,162
Pantoprazole Sodium	69	$706
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	41	$675
Esomeprazole Magnesium	18	$557
Levocetirizine Dihydrochloride	38	$467
Fluticasone Propionate	23	$364
Ofloxacin	22	$338
Mupirocin	37	$318
Prednisone	73	$311

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Birmingham

Michael SillersBirmingham$53K
Justin TurnerBirmingham$34K
Bradford WoodworthBirmingham$27K
Patrick OwensBirmingham$26K
Kirk WithrowBirmingham$22K
Do-Yeon ChoBirmingham$19K
Andrew FusonBirmingham$18K
Benjamin GreeneBirmingham$15K
William BarberBirmingham$13K
Dennis PappasBirmingham$13K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →